Company Filing History:
3 out of 14 
2 out of 1,290 
1 out of 8 Years Active: 2020-2025
Title: Raffaella Di Lucrezia: Innovator in Cancer Treatment
Introduction
Raffaella Di Lucrezia is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds. With a total of three patents to her name, her work focuses on the creation of effective therapeutic agents.
Latest Patents
Raffaella's latest patents include groundbreaking inventions such as quinoline derivatives and coumarin derivatives. The quinoline derivatives are designed for the treatment of cancer, involving compounds of a specific general formula. These compounds can be used as medicaments and are intended for use in combination with other cancer therapies. Additionally, her work on coumarin derivatives presents novel inhibitors of mitochondrial RNA polymerase, which are also aimed at treating cancer.
Career Highlights
Throughout her career, Raffaella has worked with esteemed organizations such as Lead Discovery Center GmbH and the Max Planck Society for the Advancement of Science. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community significantly.
Collaborations
Raffaella has collaborated with notable colleagues, including Tim Bergbrede and Peter Nussbaumer. These partnerships have enhanced her research efforts and fostered innovation in her field.
Conclusion
Raffaella Di Lucrezia stands out as a dedicated inventor whose work is making a difference in cancer treatment. Her innovative patents and collaborations reflect her commitment to advancing medical science.